-
Federal
Focusing on diffuse (interstitial) lung disease: a rapidly evolving field
U.S. Department of Health & Human Services —
Focusing on diffuse (interstitial) lung disease: a rapidly evolving field -
Federal
Mucus and Iron Figures
U.S. Environmental Protection Agency —
The data sets are for the figures in the manuscript. This dataset is associated with the following publication: Ghio, A., J. Soukup, L. Dailey, and V. Roggli. Mucus... -
Federal
Surfactant gene polymorphisms and interstitial lung diseases
U.S. Department of Health & Human Services —
Pulmonary surfactant is a complex mixture of phospholipids and proteins, which is present in the alveolar lining fluid and is essential for normal lung function.... -
Federal
Genetic polymorphisms in lung disease: bandwagon or breakthrough?
U.S. Department of Health & Human Services —
The study of genetic polymorphisms has touched every aspect of pulmonary and critical care medicine. We review recent progress made using genetic polymorphisms to... -
Federal
Role of endothelin-1 in lung disease
U.S. Department of Health & Human Services —
Endothelin-1 (ET-1) is a 21 amino acid peptide with diverse biological activity that has been implicated in numerous diseases. ET-1 is a potent mitogen regulator of... -
Federal
Importance of lysosomal cysteine proteases in lung disease
U.S. Department of Health & Human Services —
The human lysosomal cysteine proteases are a family of 11 proteases whose members include cathepsins B, C, H, L, and S. The biology of these proteases was largely...